The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 701–800 of 1,001
Skouby, S. O., Sidelmann, J. J., Nilas, L., Gram, J., & Jespersen, J. (2008) · Climacteric · doi:10.1080/13697130802455150 · Cited by 16
Obesidad abdominal: un estandarte del riesgo cardiometabólico
Salvador, J., Silva, C., Pujante, P., & Frühbeck, G. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)75079-4 · Cited by 17
Aeimlapa, R., Wongdee, K., Tiyasatkulkovit, W., Kengkoom, K., Krishnamra, N., & Charoenphandhu, N. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2019 · Cited by 14
A study of autonomic functions and obesity in postmenopausal women
Chaudhuri, A., Borade, N., Tirumalai, J., Saldanha, D., Ghosh, B., & Srivastava, K. (2012) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.110949 · Cited by 14
Rouen, P. A., Lukacs, J. L., & Reame, N. E. (2010) · Biological Research For Nursing · doi:10.1177/1099800410365368 · Cited by 15
“menopause, menstrual cycle, adipokines The risk for insulin resistance (IR) increases after menopause and may be related to the decline in estrogen (M. C. Carr, 2003).”
Distant regulatory effects of genetic variation in multiple human tissuesPreprint
Jo, B., He, Y. M., Strober, B. J., Parsana, P., Aguet, F., Brown, A. A., Castel, S. E., Gamazon, E. R., Gewirtz, A. D., Gliner, G., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/074419 · Cited by 16
Significant association between three atherosclerosis indexes and stroke risk
Wang, X., Wu, L., Shu, P., Yu, W., & Yu, W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315396 · Cited by 14
Shearer, K., Morrice, N., Henderson, C., Reekie, J., Mcilroy, G. D., McCaffery, P. J. A., Delibegović, M., & Mody, N. (2015) · Obesity · doi:10.1002/oby.21164 · Cited by 13
“Young female mice (and humans) are protected from obesity in an estrogen-dependent manner (9-12).”
BackgroundDiabetic Stroke Promotes a Sexually Dimorphic Expansion of T Cells
Jackson, L., Li, W., Abdul, Y., Dong, G., Baban, B., & Ergul, A. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08554-6 · Cited by 13
“1993; Carr 2003; Barrett-Connor 1997), after menopause the risk increases to equal to that in men, resulting in more severe strokes, higher short-term mortality, and a worse quality of life than men (Bushnell et al.”
BackgroundKang, E. Y., & Yim, J. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.6.488 · Cited by 13
“Hormonal changes after menopause in women have been reported to affect body fat distribution and increase metabolic risk factors associated with cardiovascular disease [50].”
BackgroundHormonal Biophysiology of the Uterus
Deligdisch, L., & Miceli, A. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38474-6_1 · Cited by 14
Combined Effects of Unhealthy Lifestyle Behaviors on Metabolic Syndrome among Postmenopausal Women
Ra, J.-S., & Kim, H. (2021) · Healthcare · doi:10.3390/healthcare9070848 · Cited by 13
“risk of type 2 diabetes mellitus (T2DM), low high-density lipoprotein (HDL) cholesterol, high low-density lipoprotein (LDL) cholesterol levels, and hypertension [9,10].”
BackgroundSandrine, M. N. Y., Owona, P. E., Noubom, M., Mbock, M. A., MbolangNguegan, L., Ngoungouré, M. C., Fifen, R. N., Goufani, R. B. A., Tadah, R. B. K., Bilanda, D. C., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6759000 · Cited by 13
Huang, S., Li, Y., Li, J., Ren, Y., Wang, J., Shi, K., Yan, W., Qian, W., & Yang, Z. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28121 · Cited by 13
“coronary microvascular endothelium impairment.(34) As a result, the concomitant presence of diabetes and menopause substantially increases the incidence and clinical severity of heart abnormalities in this group of patients.”
BackgroundShinlapawittayatorn, K., Pongkan, W., Sivasinprasasn, S., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00189-0 · Cited by 13
“Consistently, clinical evidence also demonstrates that after menopause the metabolic syndrome incidence among women increased dramatically [15].”
BackgroundHabibi, P., Ahmadiasl, N., Nourazarian, A., & Yousefi, H. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0069 · Cited by 13
Straat, M. E., Martínez‐Téllez, B., van Eyk, H. J., Bizino, M. B., van Veen, S., Vianello, E., Stienstra, R., Ottenhoff, T. H. M., Lamb, H. J., Smit, J. W. A., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac598 · Cited by 13
Gómez‐Santos, C., Morante, J. J. H., Margareto, J., Larrarte, E., Formiguera, X., Martínez, C. M., & Garaulet, M. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31820641da · Cited by 14
“In fact, a characteristic of menopause is that women present with an increase risk for a number of complex autoimmune, neurodegenerative, metabolic, and cardiovascular disorders.(5)”
BackgroundKelemen, L. E., Atkinson, E. J., de Andrade, M., Pankratz, V. S., Cunningham, J. M., Wang, A., Hilker, C. A., Couch, F. J., Sellers, T. A., & Vachon, C. M. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-156 · Cited by 15
“If the absence of estrogen leads to abdominal fat deposition, it is possible that reduced PPARG expression may act cooperatively to potentiate metabolic syndrome-related symptoms that are often associated with increased waist girth [44].”
BackgroundOvariectomized Highly Fit Rats Are Protected against Diet-Induced Insulin Resistance
Park, Y.-M., Kanaley, J. A., Zidon, T. M., Welly, R. J., Scroggins, R. J., Britton, S. L., Koch, L. G., Thyfault, J. P., Booth, F. W., Padilla, J., et al. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000898 · Cited by 14
“Postmenopausal women (3) and OVX rodents (41) develop metabolic dysfunction including increased BW and adiposity, and may be more susceptible to the negative effects of HFD.”
BackgroundChanges of liver enzymes and triglyceride during the menopausal transition in Japanese women
Matsui, S., Yasui, T., Kasai, K., Keyama, K., Kato, T., Uemura, H., Kuwahara, A., Matsuzaki, T., & Irahara, M. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2016.1154516 · Cited by 13
Park, S., Zhang, T., Yu, Y., Jeong, S.-J., Ryu, M.-S., Wu, X., Yang, H.-J., & Jeong, D. (2022) · Foods · doi:10.3390/foods11131951 · Cited by 13
“Premenopausal women have less risk for metabolic syndrome and cardiovascular diseases, but after menopause, they have an equal or higher prevalence of metabolic syndrome than men [21,36].”
BackgroundSadashiv, Tiwari, S., Paul, B. N., Kumar, S., Chandra, A., Dhananjai, S., & Negi, M. P. S. (2012) · Women s Health · doi:10.2217/whe.12.46 · Cited by 13
“The emergence of these risk factors may be a direct result of ovarian failure or alternatively an indirect result of metabolic consequences of central fat redistribution with estrogen deficiency [3].”
BackgroundPerichart‐Perera, O., Balas-Nakash, M., Muñoz‐Manrique, C., Legorreta-Legorreta, J., Rodríguez-Cano, A. M., Mier‐Cabrera, J., & Aguilera-Pérez, J. R. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000160 · Cited by 14
“cholesterol, and high-density lipoprotein (HDL) cholesterol concentrations may be altered in postmenopausal women, and there is in a 60% increase in the risk of developing metabolic syndrome.(4)”
BackgroundGhachem, A., Prud’homme, D., RABASA-LHORET, R. P. R., & Brochu, M. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000862 · Cited by 17
“This is generally explained by ovarian failure or the metabolic consequences of central fat accumulation with estrogen deficiency.(5)”
BackgroundGorres, B. K., Field, T., Schmidt, E. R., & Munger, K. A. (2018) · Physiological Reports · doi:10.14814/phy2.13783 · Cited by 14
“Following menopause, insulin insensitivity and glucose intolerance occurs, along with weight gain (Pfeilschifter et al. 2002; Sites et al. 2002; Carr 2003).”
BackgroundInfluentialImpact of Menopause on Pharmacokinetics of Rosuvastatin Compared with Premenopausal Women
Nazir, S., Iqbal, Z., & Nasir, F. (2015) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-015-0285-2 · Cited by 13
Benetti‐Pinto, C. L., Castro, N., Grassiotto, O. D. R., & Garmes, H. M. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181b00dad · Cited by 13
“H ypoestrogenism as a result of ovarian failure is suggested to increase the risk of cardiovascular disease (CVD) and metabolic syndrome.(1) Many factors may increase the risk of CVD, including enhanced adiposity and body mass index (BMI).”
BackgroundKaria, P. S., Joshu, C. E., & Visvanathan, K. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1849 · Cited by 14
“Changes that occur during natural menopause, such as increased systemic inflammation (18, 19), increased glucose and insulin levels (20), and increased proinflammatory cytokine levels (21, 22), appear to be accelerated in women who undergo premenopausal oophorectomy due to the abrupt decline in endogenous estrogen and…”
BackgroundWang, X., on behalf of the A4 Study Team, Sundermann, E. E., Buckley, R. F., Reas, E. T., McEvoy, L. K., & Banks, S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230466 · Cited by 14
“Thepost-menopausalincreaseinmetabolic syndromeisafurthercomplication,duetoitsimplica-622 tions for cerebrovascular health [39].”
Zhang, J., Cheng, Y., Chen, C., Wang, Q., Yang, C., Qiu, J., Li, J., Liu, X., Zhang, Y., Liu, L., et al. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02646-z · Cited by 12
“Menopause is a physiological age-related condition in women that is accompanied by a drop in hormone levels, especially estradiol levels [13, 14].”
BackgroundMenopause and suicide: A systematic review
Hendriks, O., McIntyre, J. C., Rose, A. K., Sambrook, L., Reisel, D., Crockett, C., Newson, L. R., & Saini, P. (2025) · Women s Health · doi:10.1177/17455057251360517 · Cited by 13
“Given the significant metabolic changes that occur during menopause 92 and their relevance for mental health, including increased suicidality, 93,94 highlights the need for future research and clinical practice to address the interplay of physical and mental health factors in menopausal suicidality.”
Amelioration of estrogen deficiency-induced obesity by collagen hydrolysate
Chiang, T.-I., Chang, I., Lee, H.-H., Hsieh, K.-H., Chiu, Y.-W., Lai, T., Liu, J.-Y., Hsu, L., & Kao, S. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.16706 · Cited by 12
“lipoprotein profile [9], which lead to metabolic syndrome [10] and the subsequent rise in the incidence of cardiovascular diseases [11].”
BackgroundCan Resistance Exercise Be a Tool for Healthy Aging in Post-Menopausal Women with Type 1 Diabetes?
Momeni, Z., Logan, J. E., Sigal, R. J., & Yardley, J. E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168716 · Cited by 35
“Alterations in lipid levels [27], such as increases in triglycerides and low-density lipoprotein cholesterol (LDL-C) and a decrease in highdensity lipoprotein cholesterol (HDL-C), are among other CVD risk factors associated with menopause [23].”
BackgroundInfluentialKoo, B. K., Park, S. H., Han, K., & Moon, M. K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1197 · Cited by 13
“In women, menopause is an independent risk factor for cardiovascular disease (CVD) [7,8] and CVD-related mortality [9] even in the same age group, menopausal status as well as age should be considered when investigating the effect of bodyweight on CVD or mortality in women; however, the impact of menopausal status on…”
BackgroundElmugadam, A., Elfadil, G. A., Hamad, A. I., Shikieri, A. B. E., Aledrissy, M., & Altayb, H. N. (2022) · Journal of Aging Research · doi:10.1155/2022/1545127 · Cited by 13
“Furthermore, CVDs are one of the most common causes of death worldwide, and their prevalence has seen a steady increase [6].”
BackgroundChu, F., Hsu, C.-H., & Jeng, C. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.02.005 · Cited by 14
Circulating Regulatory T Cells in Endometrial Cancer: A Role for Age and Menopausal Status
Sawan, S., Burt, D. J., Stern, P. L., Holland, C. M., & Elkord, E. (2010) · Immunological Investigations · doi:10.3109/08820139.2010.513022 · Cited by 14
The Metabolic Syndrome in Women: A Growing Problem for Cardiac Risk
Paul, S. C., & Smith, L. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200511000-00011 · Cited by 17
“Postmenopausal women also have an increased prevalence of small, dense LDL, but a decrease in large HDL2 particles, which are antiatherogenic.(2,47) Women with small, dense LDL have a 3-fold increased risk for CV disease than women with large, buoyant LDL.”
BackgroundMethodPrimeaux, S. D., Simon, L., Ferguson, T. F., Levitt, D. E., Brashear, M. M., Yeh, A. Y., & Molina, P. E. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14667 · Cited by 13
Shiraishi, N., Kitamura, K., Kohda, Y., Iseki, K., & Tomita, K. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0833-5 · Cited by 12
“As LDLC and TG levels are known to increase in females after menopause along with a decrease in estrogen [9], the results were not contradictory with existing knowledge.”
ResultCommunity-based Study on Summer-Winter Difference in Insulin Resistance in Kin-Chen, Kinmen, Taiwan
Chen, S.-H., Chuang, S., Lin, K., Tsai, S., & Chou, P. (2008) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70004-8 · Cited by 13
Ovariectomy Causes Degeneration of Perivascular Adipose Tissue
Nakamura, T., Miyamoto, K., Kugo, H., Sutoh, K., Kiriyama, K., Moriyama, T., & Zaima, N. (2021) · Journal of Oleo Science · doi:10.5650/jos.ess21179 · Cited by 12
Menopause and Risk for Obesity: How Important Is Physical Activity?
Evans, E. M., & Racette, S. B. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.211 · Cited by 17
An increase in epicardial fat in women is associated with thrombotic risk
Acevedo, L. B., Barrera-Hernández, S., Muñoz, M. D. J. F., García, R. P. S., Luna, A. K. R., & Murillo, C. M. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2017.10.004 · Cited by 11
Ranjbar, M., Shab‐Bidar, S., Rostamian, A., Mohammadi, H., Tavakoli, A., & Djafarian, K. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103189 · Cited by 13
Romani, A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114619 · Cited by 11
Yerba mate consumption by ovariectomized rats alters white adipose tissue
Andrade, V. M. D. M., de Moura, A. F., Chaves, K. D. C., Dias-Rocha, C. P., de Andrade, C. B. V., Trevenzoli, I. H., Ortiga-Carvalho, T. M., Barcellos, L., Vaisman, M., & Salerno, V. P. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111881 · Cited by 11
Effects of Anterior Pituitary Adenomas’ Hormones on Glucose Metabolism and Its Clinical Implications
Li, M., Zhang, J., Yang, G., Zhang, J., Han, M., Zhang, Y., & Liu, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s397445 · Cited by 12
“Hyperprolactinemia can also induce gonadotropin suppression, which may indirectly induce insulin resistance in both men and women.(34,35)”
BackgroundWohlers, L. M., Powers, B. L., Chin, E. R., & Spangenburg, E. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2012 · Cited by 12
Estrogens repress PGC1-α expression in the uterus
Macari, C., Teyssier, C., Tribollet, V., Mouzat, K., Forcet, C., Horard, B., Lobaccaro, J. A., & Vanacker, J.-M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.003 · Cited by 12
“Reduced estrogen signaling, such as the one which occurs after menopause in women, are associated with a cessation of reproductive functions, increased bone loss and the emergence of the metabolic syndrome (reviewed in Carr, 2003 and Seeman, 2003).”
BackgroundNovel approaches to anti-obesity drug discovery with gut hormones over the past 10 years
Rose, F., Bloom, S. R., & Tan, T. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1646243 · Cited by 11
Lakshmanan, S., Shekar, C., Kinninger, A., Dahal, S., Onuegbu, A., Cai, A. N., Hamal, S. A., Birudaraju, D., Cherukuri, L., Flores, F. R., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.05.014 · Cited by 12
Sau, L., Olmstead, C., Cui, L. J., Chen, A., Shah, R. S., Kelley, S. T., & Thackray, V. G. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa173 · Cited by 13
Stages of menopause and abnormal lung function: a cross-sectional study of middle-aged women
Hong, Y. S., Park, H. Y., Chang, Y., Jang, E., Zhao, D., Kim, S., Güallar, E., Kim, H., Cho, J., & Ryu, S. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001779 · Cited by 11
Sex differences in the response to circadian disruption in diurnal sand rats
Bilu, C., Kronfeld‐Schor, N., Zimmet, P., & Einat, H. (2021) · Chronobiology International · doi:10.1080/07420528.2021.1989448 · Cited by 12
Molfetta, S. D., Daniele, A., Gerardi, C., Allocati, E., Minoia, C., Loseto, G., Giorgino, F., Guarini, A., & Sanctis, V. D. (2022) · Cancers · doi:10.3390/cancers14061439 · Cited by 13
Minami, A., Matsushita, H., Horii, Y., Ieno, D., Matsuda, Y., Saito, M., Kanazawa, H., Ohyama, Y., Wakatsuki, A., Takeda, A., et al. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00657 · Cited by 11
“BMC Complement. Altern. Med., 12, 102 (2012). 9) Stajić M, Vukojevic J, Duletić-Lausević S.”
BackgroundShi, X., Zhao, C., Yang, S., Hu, X., & Liu, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/742914 · Cited by 11
Rice, B. H., Kraft, J., Destaillats, F., Bauman, D. E., & Lock, A. L. (2012) · Journal of Nutrition · doi:10.3945/jn.112.160077 · Cited by 13
A Prospective Study of Epicardial Adipose Tissue and Incident Metabolic Syndrome: The ARIRANG Study
Lee, J. H., Kim, J., Kim, K. M., Lee, J., Youn, Y. J., Ahn, M. S., Yoo, B., Lee, S., Yoon, J., Choe, K., et al. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.12.1762 · Cited by 12
“Estrogen deficiency is believed to be one of the culprits for this phenomenon (23).”
BackgroundNayak, T. K., Ramesh, C., Hathaway, H. J., Norenberg, J. P., Arterburn, J. B., & Prossnitz, E. R. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0289 · Cited by 13
“The lower prevalence of many diseases in premenopausal women compared to postmenopausal women or age-matched men is widely attributed to the presence of 17β-estradiol, the predominant and most potent endogenous estrogen (1-3).”
Banh, T., Snoke, D. B., Cole, R. M., Angelotti, A., Schnell, P., & Belury, M. A. (2019) · Oncology Reports · doi:10.3892/or.2019.7079 · Cited by 13
“The role of menopause, a condition associated with an increase in adipose mass (15), is also unclear in cancer cachexia.”
BackgroundPhysical Activity and Pattern of Blood Pressure in Postmenopausal Women With Hypertension in Nigeria
Ogwumike, O., Adeniyi, A. F., Dosa, B., Sanya, A. O., & AWOLOLA, K. A. (2014) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v24i2.8 · Cited by 11
“Increased insulin resistance has also been reported to occur at menopause causing unfavorable changes in blood pressure, lipid metabolism, body weight and the development of metabolic syndrome (30).”
BackgroundMagri, F., Gabellieri, E., Busconi, L., Guazzoni, V., Cravello, L., Valdes, V., Sorrentino, A. R., Chytiris, S., & Ferrari, E. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.036 · Cited by 11
[Metabolic syndrome in employees in Argentina].
Coniglio, R. I., Nellem, J., Gentili, R., Sibechi, N., Agusti, E., & Torres, M. (2009) · PubMed · Cited by 11
Lack of 17β-estradiol reduces sensitivity to insulin in the liver and muscle of male mice
Toda, K., Toda, A., Ono, M., & Saibara, T. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00772 · Cited by 13
“Estrogens have beneficial effects on metabolic homeostasis in addition to their roles in reproductive functions (Nuutila et al., 1995; Carr, 2003; Herrmann et al., 2002; Maffei et al., 2004; Riant et al., 2009).”
BackgroundHussain, A. A., Carlsson, J. M., Mortensen, E. L., Hemmingsen, S. D., Bulik, C. M., Støving, R. K., & Sjögren, J. M. (2024) · Journal of Eating Disorders · doi:10.1186/s40337-024-01055-3 · Cited by 11
Yang, C., Liu, X., Li, J., Yan, N., Dang, Y., Chang, Z., Wang, K., Liu, X., Zhao, Y., & Zhang, Y. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0120 · Cited by 10
Aerobic exercise prevents apoptosis in skeletal muscles of high-fat-fed ovariectomized rats
Kim, H. J., & Kwon, O. (2022) · Physical Activity and Nutrition · doi:10.20463/pan.2022.0007 · Cited by 10
Abelman, R. A., Nguyen, T. T. J., Ma, Y., Bacchetti, P., Lambert-Messerlian, G. M., French, A. L., Sharma, A., Minkoff, H., Plankey, M. W., Grünfeld, C., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad165 · Cited by 10
The Menopausal Transition: Is the Hair Follicle “Going through Menopause”?
Rinaldi, F., Trink, A., Mondadori, G., Giuliani, G., & Pinto, D. (2023) · Biomedicines · doi:10.3390/biomedicines11113041 · Cited by 11
“Indeed, the transition into menopause and the accompanying shifts in hormonal balance (e.g., systemic estradiol (E2) levels) have been linked to adverse alterations in various indicators of metabolic health [37,38].”
BackgroundWang, X., Zheng, K., Hu, X., & Pei, J. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112163 · Cited by 12
Chung, S. I., Ham, T., & Kang, M. Y. (2019) · Nutrients · doi:10.3390/nu11092184 · Cited by 10
“The absence of estrogen in postmenopausal women is known to promote metabolic disorders and increase the risk of dyslipidemia, diabetes, obesity, and osteoporosis [17,19].”
BackgroundSubhashri, S., Pal, P., Pal, G. K., Papa, D., & Nanda, N. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1817475 · Cited by 11
No Association between Metabolic Syndrome and Periodontitis in Korean Postmenopausal Women
Kim, J.-I., Choi, C., & Chung, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111110 · Cited by 11
Arisawa, K., Kaneko, M., Matsuoka, A., Ozawa, N., Kawawa, R., Ishikawa, T., Ichi, I., & Fujiwara, Y. (2023) · Nutrients · doi:10.3390/nu15061374 · Cited by 12
Aging in the Hypothalamic-Pituitary-Ovarian Axis
Neal-Perry, G. S., & Santoro, N. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50055-5 · Cited by 11
MENEGUETTE, M. V. D. O., de Oliveira, C. A., Lima, M. H. M., Kathleen Nicole, P. I. N. A., & do Amaral, M. E. C. (2016) · Revista de Nutrição · doi:10.1590/1678-98652016000100001 · Cited by 10
Chung, S. I., Ryu, S.-N., & Kang, M. Y. (2016) · Nutrients · doi:10.3390/nu8100658 · Cited by 10
“Ovarian hormone deficiency resulting from menopause or ovariectomy increases the risk of diabetes, obesity, dyslipidemia, and osteoporosis [14,17,36].”
InfluentialEffect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate
Yafasova, A., Mandrup, C. M., Egelund, J., Nyberg, M., Stallknecht, B. M., Hellsten, Y., Nielsen, L. B., & Christoffersen, C. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00527.2018 · Cited by 10
“In contrast, findings on the relationship between 168 menopause and HDL-C and triglycerides are inconsistent (7, 14, 15, 25, 38).”
BackgroundResultInfluentialAssociation Between Duration of Reproductive Years and Metabolic Syndrome
Park, Y. C., Lee, T. S., Kang, H., Cho, E. S., Kim, J. S., Hwang, Y. J., & Kim, J.-K. (2017) · Journal of Women s Health · doi:10.1089/jwh.2017.6364 · Cited by 10
“10 Similarly, a recent study reported that postmenopausal women had significantly higher BMI, abdominal fat percentage, total cholesterol, LDL-cholesterol (LDL-C), HDL-C, and TG than premenopausal women.”
資延優梨, Terauchi, M., Hirose, A., Hirano, M., Akiyoshi, M., Kato, K., & Miyasaka, N. (2018) · BMC Women s Health · doi:10.1186/s12905-018-0525-0 · Cited by 10
Romero, C. E. (2006) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 11
Buniam, J., Chansela, P., Weerachayaphorn, J., & Saengsirisuwan, V. (2023) · Biomedicines · doi:10.3390/biomedicines11072071 · Cited by 9
El incremento de la grasa epicárdica en mujeres se asocia a riesgo trombótico
Acevedo, L. B., Barrera-Hernández, S., Muñoz, M. D. J. F., García, R. P. S., Luna, A. K. R., & Murillo, C. M. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2017.10.004 · Cited by 9
Nandhini, R., Nath, B., Gaikwad, H. S., Sharma, M., & Meena, S. (2022) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_38_22 · Cited by 9
“[11] The entire cohort was above 40 years in our study and predisposition to abdominal obesity by virtue of racial susceptibility can be well accounted for the higher WC found in premenopausal women in our study when compared to other studies.[22,23] Furthermore, the role of estrogen in the possible regulation of appe…”
Schindler, L. S., Subramaniapillai, S., Ambikairajah, A., Barth, C., Crestol, A., Voldsbekk, I., Beck, D., Gurholt, T. P., Topiwala, A., Suri, S., et al. (2023) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2023.1320640 · Cited by 13
Naz, M. S. G., Farhadi‐Azar, M., Noroozzadeh, M., Farahmand, M., & Tehrani, F. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae198 · Cited by 9
Effects of high fat diet on metabolic health vary by age of menopause onset
Salinero, A. E., Venkataganesh, H., Abi‐Ghanem, C., Riccio, D. A., Kelly, R. D., Gannon, O. J., Sura, A., Brooks, H. L., Zuloaga, D. G., & Zuloaga, K. L. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01618-z · Cited by 9
Menopause and Exercise: Linking Pathophysiology to Effects
Atapattu, P. M., Fern, D., Wasalathanthri, S., & de Silva, A. (2015) · Archives of Medicine · Cited by 16
Ivić, V., Blažetić, S., Labak, I., Balog, M., Vondrak, L., Blažeković, R., Vari, S. G., & Heffer, M. (2016) · Croatian Medical Journal · doi:10.3325/cmj.2016.57.194 · Cited by 9
Loganathan, N., & Belsham, D. D. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00168.2016 · Cited by 10
Chung, S. I., Ryu, S.-N., & Kang, M. Y. (2021) · Nutrients · doi:10.3390/nu13092926 · Cited by 11
Abdominal Obesity and Metabolic Alterations in the Menopausal Transition
Berg, G. A., Mesch, V., & Siseles, N. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0011-x · Cited by 9
“We have previously discussed the behavior of leptin and adiponectin (this last one considered today as an inflammatory marker itself) in perimenopausal women and PMW.”
BackgroundInfluentialMyśliwska, J. M., Rutkowska, A. Z., Hak, Ł., Siebert, J., Szyndler, K., & Rachoń, D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.09.017 · Cited by 9
Priya, T., Chowdhury, M. G., Vasanth, K., Vijayakumar, T., Ilango, K., Agrawal, A., & Dubey, G. P. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.06.016 · Cited by 10
RetractedKim, J., Lee, Y. H., Park, J. H. Y., & Sung, M. (2015) · Nutrition Research and Practice · doi:10.4162/nrp.2015.9.6.628 · Cited by 9
“Previous studies have shown that estradiol repletion can overcome high-fat diet-induced or FFA-induced insulin resistance [28,29].”
InfluentialKim, H. J., Yoon, H. M., Kwon, O., & Lee, W. J. (2016) · Physical Activity and Nutrition · doi:10.20463/jenb.2016.09.20.3.5 · Cited by 9
A clinical prescription for heart health in midlife women
SHUFELT, C. L., Dutra, E., Torbati, T., & Ramineni, T. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.11.004 · Cited by 10
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.